Insider Selling: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CFO Sells 2,132 Shares of Stock

Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) CFO Matt Abernethy sold 2,132 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $107.39, for a total transaction of $228,955.48. Following the transaction, the chief financial officer now directly owns 27,131 shares […]

Related Keywords

Kentucky ,United States ,Virginia ,Matt Abernethy ,Neurocrine Biosciences ,Comerica Bank ,Nasdaq ,Neurocrine Biosciences Company Profile ,Cantor Fitzgerald ,Nuveen Asset Management ,Securities Exchange Commission ,Alberta Investment Management Corp ,Neurocrine Biosciences Inc ,Get Free Report ,Exchange Commission ,Biosciences Stock Down ,Investment Management Corp ,Retirement Systems ,Retirement System ,Asset Management ,Neurocrine Biosciences Daily ,Nasdaq Nbix ,Nbix ,Medical ,64125c10 ,Insider Trading ,Nsider Trades ,Stocks ,